AntoinetteJosephineWozniakMD

Clinical Trials

• Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1995 Oct 01

  Completed

  Phase 2

• S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01

  Completed

  Phase 2

• S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer Start of enrollment: 2004 Sep 01

  Terminated

  Not Applicable

• S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Start of enrollment: 2005 Nov 01

  Completed

  Phase 2

• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Start of enrollment: 2009 Sep 01

  Suspended

  Not Applicable

• A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01

  Completed

  Phase 1, Phase 2

• Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Not Applicable

• Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01

  Recruiting

  Not Applicable

• Join now to see all